NEW YORK & MADISON, N.J.--(HSMN NewsFeed)--Pfizer (NYSE: PFE ) and Wyeth (NYSE: WYE ) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at $50.19 per share, or a total of approximately $68 billion. The Boards of Directors of both companies have approved the combination.
Full text >>
Monday, January 26, 2009
Pfizer to Acquire Wyeth
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment